Search results
Found 1070 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
HCQ with antibiotics to treat COVID-19 could be dangerous for the heart
Coronavirus COVID-19 General Research
27 May 2020
Researchers from the Department of Physiology, Anatomy & Genetics (DPAG) have collaborated on an international study that demonstrates a detailed mechanistic understanding of how the anti-malaria drug, Hydroxychloroquine, combined with antibiotics, can cause adverse cardiac side-effects in COVID-19 patients. This gives weight to US Federal advice against using this combined treatment.
The UK prepares for national launch of COVID-19 digital contact tracing app with the help of Oxford Scientists
Coronavirus COVID-19 General Research
26 May 2020
The UK’s National Health Service (NHS) is finalising the release of a contact tracing app designed to slow the rate of infection for COVID-19. The tracing app, developed by the digital unit NHSx, is based on the evidence provided by a team of Oxford epidemiologists, mathematical modellers and ethicists in the Nuffield Department of Medicine, based at the Big Data Institute.
How has COVID-19 Impacted on People's Vulnerability to Mental Illness and Depression?
Coronavirus COVID-19 General Research
26 May 2020
The Oxford University COSIE study (COvid-19, Social Isolation and Emotion) is an online study which asked people about their experiences during the coronavirus lockdown in late April 2020, while also using objective tests of psychological function to measure vulnerability to mental illness such as depression.
Conspiracy beliefs reduces the following of government coronavirus guidance
Coronavirus COVID-19 General Research
22 May 2020
A new study from the University of Oxford shows that people who hold coronavirus conspiracy beliefs are less likely to comply with social distancing guidelines or take-up future vaccines.
Oxford COVID-19 vaccine to begin phase II/III human trials
Clinical Trials Coronavirus COVID-19 General Research
22 May 2020
University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers.
High COVID-19 mortality rates among those with liver disease, study finds
Coronavirus COVID-19 General Research
21 May 2020
A new international study has found high mortality rates from COVID-19 among people with chronic liver disease and cirrhosis.
Oxford leads on UK trial sites testing potential COVID-19 preventatives
Clinical Trials Coronavirus COVID-19 General Research
21 May 2020
The Diabetes Trial Unit (DTU) in the Radcliffe Department of Medicine is managing the UK sites for a global study testing if either chloroquine or hydroxychloroquine can prevent COVID-19 in vital frontline healthcare workers.
New Oxford Sparks podcast launched: How tricky is it to make a COVID-19 tracing app?
Coronavirus COVID-19 General Research
20 May 2020
In this episode of the Big Questions podcast, Dr Grant Blank (Oxford Internet Institute) gives his thoughts on how tricky it is to make a COVID-19 tracing app.
RECOVERY team reflect on International Clinical Trials Day 2020
Clinical Trials Coronavirus COVID-19 General Research
20 May 2020
How to set up a trial in nine days
Clinical Trials Coronavirus COVID-19 General Research
20 May 2020
Why we need the human touch in contact tracing for coronavirus
Coronavirus COVID-19 General Research
19 May 2020
T cell responses may be key to fighting off COVID-19
Coronavirus COVID-19 General Research
19 May 2020
An analysis of blood samples from COVID-19 patients has found that patients with elevated levels of a marker for T cells activity went on to develop only mild symptoms. The study, led by Professor Tao Dong (Radcliffe Department of Medicine) found that patients with lower levels of this marker had more severe symptoms.
Interdisciplinary project could lead to a personalised approach for mood stabilisation for bipolar patients
General Research
18 May 2020
An interdisciplinary project with scientists and clinicians from across the Medical Sciences Division used bipolar patient-derived fibroblasts to gain a deeper understanding into patient circadian rhythms, and how these rhythmic changes could predict lithium sensitivity in bipolar disorder.
Funding and manufacturing boost for UK vaccine programme
Awards and Appointments Clinical Trials Coronavirus COVID-19 General Research
18 May 2020
The Government has announced £65.5 million of new funding for the vaccine being developed at the University of Oxford as coronavirus vaccine trials accelerate.
Oxford University and Sichuan University form joint Centre for Gastrointestinal Cancer
General Research
15 May 2020
University of Oxford-Sichuan University Huaxi Joint Centre for Gastrointestinal Cancer, a new international collaboration led by Prof. David Kerr (Radcliffe Department of Medicine, University of Oxford) and Prof. Li Yang (Sichuan University) was launched today, Friday 15 May 2020.
How research on ticks could offer potential COVID-19 breakthrough
Coronavirus COVID-19 General Research
15 May 2020
Radcliffe Department of Medicine's Professor Shoumo Bhattacharya has been working with a UK-based biotechnology firm to find out if his research on the ‘pharmacological goldmine’ in tick saliva might offer a treatment option for COVID-10 patients.
New weight-loss drug brings hope for safer obesity treatment
General Research
14 May 2020
A collaborative research team from the Universities of Oxford and Cambridge, co-led by Department of Physiology, Anatomy & Genetics Associate Professor Ana Domingos, have developed a new weight-loss amphetamine that could potentially avoid the harmful side effects of traditional treatments.
New weapon identified in arsenal against disease
General Research
13 May 2020
Researchers in the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) reveal supramolecular attack particles are autonomous killing entities released from cytotoxic T lymphocytes
Pregnant women are not at greater risk of severe COVID-19 than other women
Coronavirus COVID-19 General Research
12 May 2020
Researchers from the Nuffield Department of Population Health, in collaboration with the Royal College of Obstetricians and Gynaecologists, the Universities of Leeds and Birmingham, Kings and Imperial Colleges London, have published new research that suggests pregnant women are no more likely to become ill with severe COVID-19 than non-pregnant woman. However, the majority of women who did become severely ill were in their third trimester of pregnancy, emphasising the importance of social distancing for this group.
Coronavirus: scientists promoting chloroquine and remdesivir are acting like sports rivals
Coronavirus COVID-19 General Research
12 May 2020